BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 10708182)

  • 21. Fibrin formation, fibrinopeptide A release, and platelet thrombus dimensions on subendothelium exposed to flowing native blood: greater in factor XII and XI than in factor VIII and IX deficiency.
    Weiss HJ; Turitto VT; Vicic WJ; Baumgartner HR
    Blood; 1984 May; 63(5):1004-14. PubMed ID: 6713090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous thrombin potential as marker of procoagulant response that can be useful in early stage of sepsis.
    Mihajlovic D; Brkic S; Lendak D; Novakov Mikic A; Draskovic B; Mitic G
    Blood Coagul Fibrinolysis; 2017 Sep; 28(6):460-467. PubMed ID: 28166112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Markers of coagulation and platelet activation during percutaneous mitral valvuloplasty.
    Fernández MA; Villa P; España F; Aznar J; Rincón de Arellano A; Cebolla R
    Blood Coagul Fibrinolysis; 1998 Oct; 9(7):581-5. PubMed ID: 9863705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of long-term and high-dose antithrombin supplementation on coagulation and fibrinolysis in patients with severe sepsis.
    Hoffmann JN; Mühlbayer D; Jochum M; Inthorn D
    Crit Care Med; 2004 Sep; 32(9):1851-9. PubMed ID: 15343012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a Recombinant Human Soluble Thrombomodulin on Baseline Coagulation Biomarker Levels and Mortality Outcome in Patients With Sepsis-Associated Coagulopathy.
    Levi M; Vincent JL; Tanaka K; Radford AH; Kayanoki T; Fineberg DA; Hoppensteadt D; Fareed J
    Crit Care Med; 2020 Aug; 48(8):1140-1147. PubMed ID: 32697484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do coagulation screening tests detect increased generation of thrombin and plasmin in sick newborn infants?
    Schmidt B; Vegh P; Johnston M; Andrew M; Weitz J
    Thromb Haemost; 1993 May; 69(5):418-21. PubMed ID: 8322263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistent hypocoagulability in patients with septic shock predicts greater hospital mortality: impact of impaired thrombin generation.
    Massion PB; Peters P; Ledoux D; Zimermann V; Canivet JL; Massion PP; Damas P; Gothot A
    Intensive Care Med; 2012 Aug; 38(8):1326-35. PubMed ID: 22735856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of conditions of blood sampling on coagulation activation markers (prothrombin fragment 1 + 2, thrombin-antithrombin complexes and D-dimers) measurements.
    Leroy-Matheron C; Gouault-Heilmann M
    Thromb Res; 1994 May; 74(4):399-407. PubMed ID: 8085241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance.
    Catena C; Zingaro L; Casaccio D; Sechi LA
    Am J Med; 2000 Nov; 109(7):556-61. PubMed ID: 11063957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of sepsis-induced coagulation abnormalities: an early assessment in the emergency department.
    Innocenti F; Gori AM; Giusti B; Tozzi C; Donnini C; Meo F; Giacomelli I; Ralli ML; Sereni A; Sticchi E; Zari M; Caldi F; Tassinari I; Zanobetti M; Marcucci R; Pini R
    Intern Emerg Med; 2019 Apr; 14(3):459-466. PubMed ID: 30535649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased heparin-releasable platelet factor 4 and D dimer in patients one month after the onset of acute myocardial infarction: persistent activation of platelets and the coagulation/fibrinolytic system.
    Abe S; Maruyama I; Arima S; Yamaguchi H; Okino H; Hamasaki S; Yamashita T; Nomoto K; Tahara M; Atsuchi Y
    Int J Cardiol; 1994 Dec; 47(1 Suppl):S7-12. PubMed ID: 7737755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Markers of coagulation activation after hepatic resection for cancer: evidence of sustained upregulation of coagulation.
    Weinberg L; Scurrah N; Parker FC; Dauer R; Marshall J; McCall P; Story D; Smith C; McNicol L
    Anaesth Intensive Care; 2011 Sep; 39(5):847-53. PubMed ID: 21970128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock.
    Brunkhorst FM; Wegscheider K; Forycki ZF; Brunkhorst R
    Intensive Care Med; 2000 Mar; 26 Suppl 2():S148-52. PubMed ID: 18470710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological inhibition of plasma coagulation and platelet activation during experimental long-term perfusion.
    Skogby M; Friberg LG; Adrian K; Mellgren K
    Scand Cardiovasc J; 2003 Sep; 37(4):222-8. PubMed ID: 12944211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of markers of activated coagulation in antithrombin III deficient subjects.
    Demers C; Ginsberg JS; Henderson P; Ofosu FA; Weitz JI; Blajchman MA
    Thromb Haemost; 1992 May; 67(5):542-4. PubMed ID: 1519214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemostasis activation markers in acute renal failure.
    Stefanidis I; Frank D; Maurin N
    Ren Fail; 1998 Jan; 20(1):147-55. PubMed ID: 9509568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Procollagen type III aminoterminal propeptide as biomarker of host response in severe sepsis.
    Zakynthinos S; Papanikolaou S; Mentzelopoulos S; Konstandelou E; Psachoulia C; Mavrommatis A
    J Crit Care; 2013 Oct; 28(5):577-85. PubMed ID: 23683562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of coagulation system in dilated cardiomyopathy: comparison of patients with and without left ventricular thrombus.
    Riza Erbay A; Turhan H; Aksoy Y; Senen K; Yetkin E
    Coron Artery Dis; 2004 Aug; 15(5):265-8. PubMed ID: 15238823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levels of circulating microparticles in septic shock and sepsis-related complications: a case-control study.
    Boscolo A; Campello E; Bertini D; Spiezia L; Lucchetta V; Piasentini E; Radu CM; Manesso L; Ori C; Simioni P
    Minerva Anestesiol; 2019 Jun; 85(6):625-634. PubMed ID: 30481997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality.
    Mauri T; Bellani G; Patroniti N; Coppadoro A; Peri G; Cuccovillo I; Cugno M; Iapichino G; Gattinoni L; Pesenti A; Mantovani A
    Intensive Care Med; 2010 Apr; 36(4):621-9. PubMed ID: 20119647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.